Beta interferon inhibits HIV-1 Tat-induced angiogenesis: Synergism with 13-cis retinoic acid

European Journal of Cancer

Volumn 34, Issue 4, 1998, Pages 570-576

  Iurlaro, M ^a,c   Benelli, R ^a,b   Masiello, L ^a,b   Rosso, M ^b   Santi, L ^a,b   Albini, A ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Angiogenesis; HIV 1; Interferon; Retinoids; Tat

Indexed keywords

BETA INTERFERON; FRONE 3 000 000; INTERFERON; ISOTRETINOIN; RETINOID; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PATHOGENESIS; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; DRUG SYNERGISM; ENDOTHELIUM, VASCULAR; GENE PRODUCTS, TAT; HUMANS; INTERFERON-BETA; LUNG NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0032033453     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)10082-X     Document Type: Article

References (55)

1. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992, 3, 65-71.
2. Liotta L, Steeg P, Stetler-Stevenson W. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64, 327-336.
3. Kaposi M. Idiopathisches multiples pigment Sarcom der Haut. Arch DermatolSyph 1872, 4, 265-273.
4. Friedman-Kien AE, Laubenstein W, Rubenstein PLJ. et al. Disseminated Kaposi's sarcoma in homosexual men. Ann Intern Med 1982,96, 693-700.
5. Roth WK, Brandstetter H, Sturzl M. Cellular and molecular features of HIV-associated Kaposi's sarcoma. AIDS 1992, 6, 895-913.
6. Armes J. A review of Kaposi's sarcoma. Adv Cancer Res 1989,53, 73-87.
7. Nakamura S, Salahuddin SZ, Biberfeld P, et al. Kaposi's sarcoma cells: long-term culture with growth factor from retrovirusinfected CD4+T cells. Science 1988, 242, 426-429.
8. Uccini S, Ruco L, Monardo F, et al. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells. J Paz/zo/1994, 173, 23-31.
9. Kaaya E, Parravicini C, Ordonez C, et al. Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture. J Acq Immun Def Synd Hum Retrovirol 1995, 10, 295-305.
10. Nickoloff BJ, Griffiths GEM. The spindle-shaped cells in cutaneous Kaposi's sarcoma. AmJPathol 1989, 135, 793-800.
11. Popescu NC, Zimonjic DB, Leventon KS, Bryant JL, Lunardi IY, Gallo RC. Deletion and translocation involving chromosome 3 (pi4) in two tumorigenic Kaposi's sarcoma cell lines. J Natl Cancer Inst 1996, 88, 450-455.
12. Lunardi-Iskandar Y, Gill P, Lam V, et al. Isolation and characterization of an immortal neoplastic cell line (KSY-1) from AIDS-associated Kaposi's Sarcoma. J Natl Cancer Inst 1995, 87, 974-981.
13. Albini A, Paglieri I, Orengo G, et al. The β-core fragment of human Chorionic Gonadotropin (hCG) inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line. AIDS 1997, 11, 713-721.
14. Chang Y, Cesarman E, Pessin MS, et al. Identification of Herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266, 1865-1869.
15. Ensoli B, Nakamura S, Salahuddin SZ, et al. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989, 243, 223-226.
16. Albini A, Fontanini G, Masiello L, et al. Angiogenic potential in vivo by Kaposi sarcoma cell-free supernatants and HIV l-tat product: inhibition of KS-like lesions by TIMP-2. AIDS 1994, 8, 1237-1244.
17. Vogel J, Hinrichs SH, Reynolds RK, Luciw PA, Jay G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 1988, 335, 606-611.
18. Corallini A, Altavilla G, Pozzi L, et al. Systemic expression of HIV1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. Cancer Res 1993, 53, 5569-5575.
19. Ensoli B, Barillari G, Salahuddin SZ, Gallo R, Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990, 345, 84-86.
20. Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sei USA 1995, 92, 4838-4842.
21. Albini A, Benelli R, Presta M, et al. HIV-tat protein is a heparin-binding angiogenic growth factor. Oncogene 1996, 12, 289-297.
22. Albini A, Soldi R, Giunciuglio D, et al. HIV-1 Tat induced angiogenesis is mediated by activation of the flk-1 /KDR tyrosine kinase receptor on vascular endothelial cells. Nature Med 1996, 2, 1371-1375.
23. Murphy AN, Unsworth EJ, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 1993, 157, 351-358.
24. Folkman J, Ingber D. Inhibition of angiogenesis. Semin Cancer Biol 1992, 3, 89-96.
25. Gutterman JU. Cytokine therapeutics: lessons from interferon alpha. Proc Natl Acad Sei USA 1994, 91, 1198-1205.
26. Lilenbaum RC, Ratner L. Systemic treatment of Kaposi's sarcoma: current status and future directions. AIDS 1994,8,141 -151.
27. Sulis E, Floris C, Sulis ML, et al. Interferon administered intralesionally in skin and oral cavity lesions in heterosexual drug addicted patients with AIDS-related kaposi's sarcoma. Eur J Cancer Clin Oncol 1989, 25, 759-761.
28. Nishimura J, Mitsui K, Ishikawa T, et al. Antitumor and antimetastatic activities of human recombinant interferon alpha. Clin Exp Metast 1985, 3, 295-304.
29. Hujanen ES, Turpeenniemi-Hujanen TM. Recombinant interferon-alpha modulates the invasive potential of human melanoma in-vitro. Anticancer Res 1988, 8, 1066.
30. Wadler S, Schwanz E. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review. Cancer Res 1990, 50, 34733486.
31. Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N, Fidler IJ. Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sei USA 1995, 92, 4562-4566.
32. Melchiori A, Allavena G, Bohm J, et al. Interferons inhibit chemotaxis of transformed cells and their invasion of a reconstituted basement membrane. Anticancer Res 1987, 7, 475-480.
33. Gohji K, Fidler IJ, Tsan RJ, et al. Human recombinant interferons-beta and -gamma decrease gelatinase production and invasion by human KG-2 renal-carcinoma cells. Int J Cancer 1994,58,380-384.
34. Fidler IJ. Angiogenesis and metastasis growth factors. Clin Exp Metast 1996, 14, 30.
35. Hong WK, Tri LM. Retinoids in human cancer. In Sporn, Roberts, Goodman, eds. The Retinoids: Biology, Chemistry and Medicine, 1994.
36. Hendrix M, Wood W, Seftor E, et al. Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res 1990, 50, 4121-4130.
37. Majewski S, Marczak M, Szmurlo A, Jablonska S, Bollag W. Retinoids, interferon alpha, 1,25-dihydroxyvitamin D3 and their combination inhibit angiogenesis induced by non-HPV-harboring tumor cell lines. RARa mediates the antiangiogenic effect of retinoids. Cancer Lett 1995, 89, 117-124.
38. Kleinman HK, McGarvey ML, Hassell JR, et al. Basement membrane complexes with biological activity. Biochemistry 1986, 25,312-318.
39. Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VHI-related antigen established by hybridization. Proc Natl Acad Sei USA 1983, 80, 3734-3737.
40. Benelli R, Repetto L, Carlone S, Parravicini C, Albini A. Establishment and characterization of two new Kaposi's sarcoma cell cultures from an AIDS and a non-AIDS patient. Res Virol 1994, 145,251-259.
41. Passaniti A, Taylor RM, Pili R, et al. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 1992, 67, 519-528.
42. Postlethwaite AE, Snyderman R, Kang AH. The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J ExpMed 1976, 144, 1188.
43. Albini A, Allavena G, Melchiori A, et al. Chemotaxis of 3T3 and SV3T3 cells to fibronectin is mediated through the cell attachment site in fibronectin and a fibronectin cell surface receptor. J CellBiol 1987, 105, 1867-1872.
44. Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987, 47, 3239-3245.
45. Grant DS, Tashiro K, Segui-Real B, Yamada Y, Martin GR, Kleinman HK. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 1989, 58, 933-943.
46. Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S. HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. J Immunol 1996, 157, 974-977.
47. Köster RBL, M SM, Zietz G, Hermeking H, Brysch W, Sturzle M. Consensus-interferon and platelet-derived growth factor adversely regulate proliferation and migration of Kaposi's sarcoma cells by control of c-myc expression. Am J Pathol 1996, 149, 1871-1885.
48. Hamilton JA, Whitty GA, Kola I, Hertzog PJ. Endogenous IFNalpha beta suppresses colony-stimulating factor (CSF)-l-stimulated macrophage DNA synthesis and mediates inhibitory effects of lipopolysaccharide and TNF-alpha. J Immunol 1996, 156, 2553-2557.
49. Tamm I, Kikuchi T, Kreutter D, Pledger WJ, Pfeffer LM. Selective interferon-alpha/beta effects on platelet-derived growth factor-stimulated processes in quiescent BALB/C-3T3 fibroblasts. J Interferon Res 1994, 14, 265-273.
50. lacopino F, Ferrandina G, Scambia G, Benedetti PP, Mancuso S, Sica G. Interferons inhibit EGF-stimulated cell growth and reduce EGF binding in human breast cancer cells. Anticancer Res 1996, 16, 1919-1924.
51. Brem H, Gresser I, Grosfeld J, Folkman J. The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J Pediatr Surg 1993,28, 1253-1257.
52. Kato N, Nawa A, Tamakoshi K, et al. Suppression of gelatinase production with decreased invasiveness of choriocarcinoma cells by human recombinant interferon beta. Am J Obstet Gynecol 1995, 172, 601-606.
53. Wood WR, Seftor EA, Lotan D, et al. Retinoic acid inhibits human melanoma tumor cell invasion. Anticancer Res 1990, 10, 423-432.
54. Guo WX, Gill P, Antakly T. Inhibition of AIDS-Kaposi's Sarcoma proliferation following retinoic acid receptor activation. Cancer Res 1995, 55, 823-829.
55. Benelli R, Masiello L, Paglialunga G, et al. IFNa inhibits Tatinduced angiogenesis. Guenounoued. Paris, Inserm, 1997,447158.